Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention

International Journal of Cardiology

Volumn 223, Issue , 2016, Pages 412-417

  Chung, Sheng Ying ^a   Tong, Meng Shen ^a   Sheu, Jiunn Jye ^a   Lee, Fan Yen ^a   Sung, Pei Hsun ^a   Chen, Chien Jen ^a   Yang, Cheng Hsu ^a   Wu, Chiung Jen ^a   Yip, Hon Kan ^a,b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

Extracorporeal membrane oxygenator support; Primary percutaneous coronary intervention; Profound cardiogenic shock; Short term and long term outcomes

Indexed keywords

CREATININE;

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CLINICAL TRIAL; CREATININE BLOOD LEVEL; EARLY INTERVENTION; EXTRACORPOREAL OXYGENATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GUIDING CATHETER; HEART MUSCLE REPERFUSION; HEMATOMA; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INCIDENCE; INTRAAORTIC BALLOON PUMP; ISCHEMIA; LENGTH OF STAY; LONG TERM SURVIVAL; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEMBRANE OXYGENATOR; MIDDLE AGED; MORTALITY RATE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POPLITEAL ARTERY ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY FAILURE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; SURVIVOR; VASCULAR DISEASE; VENTILATOR WEANING; COMPLICATION; EPIDEMIOLOGY; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; SHOCK, CARDIOGENIC; ST ELEVATION MYOCARDIAL INFARCTION; TAIWAN; TIME FACTOR; TRENDS;

EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; ST ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TAIWAN; TIME FACTORS;

EID: 84982090908     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.08.068     Document Type: Article

References (35)

1. [1] Chen, J.S., Ko, W.J., Yu, H.Y., Lai, L.P., Huang, S.C., Chi, N.H., et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit. Care Med. 34 (2006), 950–957.
2. [2] Murray, C.J., Lopez, A.D., Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 (1997), 1436–1442.
3. [3] Murray, C.J., Lopez, A.D., Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 (1997), 1269–1276.
4. [4] Stone, G.W., Maehara, A., Witzenbichler, B., Godlewski, J., Parise, H., Dambrink, J.H., et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 307 (2012), 1817–1826.
5. [5] Wallentin, L., Becker, R.C., Budaj, A., Cannon, C.P., Emanuelsson, H., Held, C., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361 (2009), 1045–1057.
6. [6] Yusuf, S., Zhao, F., Mehta, S.R., Chrolavicius, S., Tognoni, G., Fox, K.K., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345 (2001), 494–502.
7. [7] Svilaas, T., Vlaar, P.J., van der Horst, I.C., Diercks, G.F., de Smet, B.J., van den Heuvel, A.F., et al. Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med. 358 (2008), 557–567.
8. [8] Yip, H.K., Chung, S.Y., Chai, H.T., Youssef, A.A., Bhasin, A., Yang, C.H., et al. Safety and efficacy of transradial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience. Circ. J. 73 (2009), 2050–2055.
9. [9] Yip, H.K., Wu, C.J., Chang, H.W., Fang, C.Y., Yang, C.H., Chen, S.M., et al. Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am. J. Cardiol. 92 (2003), 1331–1335.
10. [10] Ho, Y.C., Tsai, T.H., Sung, P.H., Chen, Y.L., Chung, S.Y., Yang, C.H., et al. Minimizing door-to-balloon time is not the most critical factor in improving clinical outcome of ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Crit. Care Med. 42 (2014), 1788–1796.
11. [11] Task Force on the management of STseamiotESoC, Steg, P.G., James, S.K., Atar, D., Badano, L.P., Blomstrom-Lundqvist, C., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 33 (2012), 2569–2619.
12. [12] Abdel-Wahab, M., Saad, M., Kynast, J., Geist, V., Sherif, M.A., Richardt, G., et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am. J. Cardiol. 105 (2010), 967–971.
13. [13] Sheu, J.J., Tsai, T.H., Lee, F.Y., Fang, H.Y., Sun, C.K., Leu, S., et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit. Care Med. 38 (2010), 1810–1817.
14. [14] Yip, H.K., Wu, C.J., Chang, H.W., Chen, M.C., Hang, C.L., Fang, C.Y., et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. Am. J. Cardiol. 87 (2001), 1184–1188 (A4).
15. [15] Lawler, P.R., Filion, K.B., Eisenberg, M.J., Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 162 (2011), 571–584 (e2).
16. [16] Levine, G.N., Bates, E.R., Blankenship, J.C., Bailey, S.R., Bittl, J.A., Cercek, B., et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the society for cardiovascular angiography and interventions. Circulation 133 (2016), 1135–1147.
17. [17] The GUSTO Angiographic Investigators, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N. Engl. J. Med. 329 (1993), 1615–1622.
18. [18] Brener, S.J., Maehara, A., Dizon, J.M., Fahy, M., Witzenbichler, B., Parise, H., et al. Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction) trial. JACC Cardiovasc. Interv. 6 (2013), 718–724.
19. [19] ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988), 349–360.
20. [20] Sanborn, T.A., Sleeper, L.A., Bates, E.R., Jacobs, A.K., Boland, J., French, J.K., et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J. Am. Coll. Cardiol. 36 (2000), 1123–1129.
21. [21] Thiele, H., Zeymer, U., Neumann, F.J., Ferenc, M., Olbrich, H.G., Hausleiter, J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367 (2012), 1287–1296.
22. [22] Hochman, J.S., Buller, C.E., Sleeper, L.A., Boland, J., Dzavik, V., Sanborn, T.A., et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK trial registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J. Am. Coll. Cardiol. 36 (2000), 1063–1070.
23. [23] Hochman, J.S., Sleeper, L.A., Webb, J.G., Sanborn, T.A., White, H.D., Talley, J.D., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N. Engl. J. Med. 341 (1999), 625–634.
24. [24] Izumikawa, T., Sakamoto, S., Takeshita, S., Takahashi, A., Saito, S., Outcomes of primary percutaneous coronary intervention for acute myocardial infarction with unprotected left main coronary artery occlusion. Catheter. Cardiovasc. Interv. 79 (2012), 1111–1116.
25. [25] Tsao, N.W., Shih, C.M., Yeh, J.S., Kao, Y.T., Hsieh, M.H., Ou, K.L., et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. J. Crit. Care, 27, 2012, 530, e1-11.
26. [26] Wu, M.Y., Tseng, Y.H., Chang, Y.S., Tsai, F.C., Lin, P.J., Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization. Resuscitation 84 (2013), 940–945.
27. [27] Chung, S.Y., Sheu, J.J., Lin, Y.J., Sun, C.K., Chang, L.T., Chen, Y.L., et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study. Circ. J. 76 (2012), 1385–1392.
28. [28] Sung, P.H., Wu, C.J., Yip, H.K., Is extracorporeal membrane oxygenator a new weapon to improve prognosis in patients with profound cardiogenic shock undergoing primary percutaneous coronary intervention?. Circ. J. 80 (2016), 572–578.
29. [29] Antoniucci, D., Valenti, R., Santoro, G.M., Bolognese, L., Trapani, M., Moschi, G., et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J. Am. Coll. Cardiol. 31 (1998), 294–300.
30. [30] Hochman, J.S., Sleeper, L.A., Webb, J.G., Dzavik, V., Buller, C.E., Aylward, P., et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (2006), 2511–2515.
31. [31] Thiele, H., Schuler, G., Neumann, F.J., Hausleiter, J., Olbrich, H.G., Schwarz, B., et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial. Am. Heart J. 169 (2015), e7–e8.
32. [32] Thiele, H., Zeymer, U., Neumann, F.J., Ferenc, M., Olbrich, H.G., Hausleiter, J., et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382 (2013), 1638–1645.
33. [33] Unverzagt, S., Buerke, M., de Waha, A., Haerting, J., Pietzner, D., Seyfarth, M., et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst. Rev., 3, 2015, CD007398.
34. [34] Chen, Y.S., Lin, J.W., Yu, H.Y., Ko, W.J., Jerng, J.S., Chang, W.T., et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372 (2008), 554–561.
35. [35] Tsai, T.H., Yeh, K.H., Sun, C.K., Yang, C.H., Chen, S.M., Hang, C.L., et al. Estimated glomerular filtration rate as a useful predictor of mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am. J. Med. Sci. 345 (2013), 104–111.